DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
-1.96%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$114M
AUM Growth
-$29.8M
(-21%)
Cap. Flow
-$29.2M
Cap. Flow
% of AUM
-25.64%
Top 10 Holdings %
Top 10 Hldgs %
42.25%
Holding
85
New
11
Increased
13
Reduced
16
Closed
19
Top Buys
| 1 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$4.1M |
| 2 |
iShares Biotechnology ETF
IBB
|
$2.31M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$2.03M |
| 4 |
Cidara Therapeutics
CDTX
|
$1.66M |
| 5 |
ADXS
Advaxis, Inc.
ADXS
|
$1.25M |
Top Sells
Sector Composition
| 1 | Healthcare | 81.51% |